«Telencephalon

Below is an extended Telencephalon patents listing. Click here to return to the Telencephalon main in depth entry.

Patents :
US Patent No.	Title
7147853	Anti-pro211 polypeptide antibodies
7217789	Fluorescent timer proteins and methods for their use
7220775	Compound useful for the treatment of neuropathic pain
7220838	Antibodies that specifically bind hedgehog-derived polypeptides
7223586	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7241865	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7252945	DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
7264793	Numb protein expression inhibitors by Musashi
7273888	Use of difluoromethylornithine (DFMO) for the treatment of amyotrophic lateral sclerosis
7276339	DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
7282621	Somatic recombination
7211602	Treatment of neurodegenerative disorders through the modulation of the polyamine pathway
7211434	Primitive neural stem cells and method for differentiation of stem cells to neural cells
7208312	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7148192	Neuroprotective dietary supplement
7151088	Neuroprotective dietary supplement
7151160	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7157267	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7160868	Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
7169906	PRO211 polypeptides
7176345	Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor
7192583	Methods for modulating bone mineralization
7198903	Binding domains between presenilins and their substrates as targets for drug screening
7208308	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7294463	Method of screening for compounds that modulate activity of a regulatory sequence of the .beta.-2 subunit of a neuronal nicotinic acetylcholine receptor
7303912	Cultures of GFAP nestin cells that differentiate to neurons
7371719	Self-assembly of peptide-amphiphile nanofibers under physiological conditions
7375222	2,4,6-Triamino-1,3,5-triazine derivative
7378507	PRO217 polypeptides
7381561	Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
7390879	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7393526	Systemic gene delivery vehicles for the treatment of tumors
7393642	Methods and primers for diagnosing idiopathic congenital central hypoventilation syndrome
7393686	Genetic demonstration of requirement for NKX6.1 and NKX2.2 in ventral neuron generation
7393830	Prolactin induced increase in neural stem cell numbers
7407766	Screening method for agonists or antagonists of semaphorin 6C by determining the effect of a test compound on the interaction between semaphorin 6C and plexin-A1
7371535	Processes for determining compounds that interact with snorf33 receptor
7365163	GABA.sub.A receptor epsilon subunits
7364900	Multi-lineage directed induction of bone marrow stromal cell differentiation
7307152	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7312081	Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation
7314968	Transgenic fish and .beta.-catenin signaling pathway model
7317092	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7319103	Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders
7319138	Human DRG11-Responsive Axonal Guidance and Outgrowth of Neurite (DRAGON) proteins and variants thereof
7320872	Ependymal neural stem cells and method for their isolation
7323616	Genetically altered mice deficient in functional caspase-9
7355002	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7357934	Intracranial botulinum toxin therapy for focal epilepsy
7416848	DNA encoding SNORF25 receptor

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.